SEC Form 4 · accession 0001144204-18-053247
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glynn Wilson
Director
Period of report
Oct 9, 2018
Accepted (ET)
Oct 10, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 9, 2018 | A | 31,120 | $0.00 | A | 189,337 | D | |
| Common StockF2 | Oct 9, 2018 | F | 7,561 | $0.00 | D | 181,776 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Employment Agreement (right to receive)F3 | — | Oct 9, 2018 | M | 31,120 | D | — | — | Common Stock | 31,120 | 0 | D |
Explanation of responses
- F1Represents issuance of fully vested shares of common stock under the Company's 2014 Omnibus Stock Ownership Plan pursuant to the Company's obligation to do so under the terms of the Reporting Person's employment agreement as amended.
- F2Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the stock award.
- F3Represents elimination of Reporting Person's right to receive shares under his employment agreement following the issuance of the shares to the Reporting Person reflected on Table I by the Company.